ClinicalTrials.gg
CompletedNCT02822469TEMCMAPTTSUpdated Feb 21, 2022

Thermograph Evaluation of Masticatory and Cervical Muscles After Physiotherapeutic Treatment in Tmd Subjects

An interventional study of Manual Therapy Treatment and Placebo Ultrasound in Temporomandibular Joint Dysfunction, sponsored by Daniela Ap. Biasotto-Gonzalez. Completed at 1 site in Brazil. Open to participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2022-02-21.

Sponsored by Daniela Ap. Biasotto-Gonzalez · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 44 studies in Temporomandibular Joint Disorders with a site in Brazil — 7 open to participants now, 7 under way, none of them phase 3. Temporomandibular Joint Disorders · Brazil.

Enrollment
23rd of 36
30 · median 40
Started
2016
with 4 others
No phase
28 of 44
5 open now
Registered
25th of 44
by date
Lead sponsor
2 of 44
Daniela Ap. Biasotto-Gonzalez

Among the 44 studies in Temporomandibular Joint Disorders with a site in Brazil, this one is the 23rd largest by enrollment of the 36 interventional ones that give a count, is one of 5 that started in 2016, is one of 28 with no phase, and was the 25th registered.

Temporomandibular Joint Disorders

593 studies on the registry are indexed under Temporomandibular Joint Disorders; 149 are open to participants now.

Browse Temporomandibular Joint Disorders studies →

Open to participants now

7 of the 44 studies in Temporomandibular Joint Disorders with a site in Brazil are open now. Recruiting first, the newest first:

2 more — sign in →

All 7 open studies →

A study can be open while its sites in Brazil have not opened yet or have stopped. Only those recruiting at a site in Brazil →

Who these studies take

Of the 76 Temporomandibular Joint Disorders studies recruiting now, 26 (34%) set no upper age limit and 46 (61%) stop at 75 or younger; 7 take children under 18; 23 take healthy volunteers.

This study: 18 Years to 45 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 44 studies in Temporomandibular Joint Disorders with a site in Brazil, or all of them as a file.
02

Study summary

Background: Different therapeutic approaches have been proposed for the treatment of TMD. Myofascial and joint techniques, exercises, intraoral devices, thermal, electro and phototherapy applications, are among the most common. The combination of local treatments and adjacent structures such as the cervical region have also been studied in this area. It is believed that the anatomic proximity, neuronal interconnections and convergent afferents from the trigeminal and cervical areas can lead the understanding of the relationship of these structures. In order to assess the effects of these different forms of treatment studies have used different resources such as diagnostic imaging and biological signals, in order to complement the clinical diagnosis. Infrared thermography has been one of the resource assessment in the literature and it is interesting and stands out from other methods because it is functional, non-invasive and inexpensive.

Purpose: To evaluate the thermograms concerning the masseter and anterior temporal muscles, severity, pain, range of mandibular motion and neck disability in TMD patients, before and after physical therapy applied to the cervical and thoracic regions.

Methods: This is a randomized, placebo-controlled study, designed to evaluate the effects of indirect treatment on the thermography of the masticatory muscles, severity, pain, range of motion and neck disability in individuals with TMD. These will be randomized and allocated into two groups: GA (intervention) and GB (placebo) and assessed as: Diagnostic Criteria for Temporomandibular Research Disorders (RDC/TMD), Fonseca´s Anamnesic Index (FAI), Thermography, EVA, IDD-CF, Pachymetry and Neck Disability Index (NDI).

Statistical analysis: The temperature of the orofacial region, acquired through thermography is considered the primary endpoint and as a secondary endpoint will be the evaluation of the severity according to FAI, pain by VAS and IDD-CF, the range of mandibular motion by pachymetry and neck disability by NDI.

Statistical analysis: The normality of the data will be verified using the Kolmogorov-Smirnov test, which will be expressed as mean and standard deviation and/or median and interquartile range. Repeated measures analysis of variance of two factors, post hoc Bonferroni will be used for inter and intra-group comparisons. The significance level of p≤0.05 is set.

Read the detailed description

This is a randomized, placebo-controlled, study designed to evaluate the thermograms concerning the masseter and anterior temporal muscles, severity, pain, range of mandibular motion and neck disability in TMD patients, before and after physical therapy applied to the cervical and thoracic regions.

03

Conditions studied

  • Temporomandibular Joint Dysfunction

Keywords

  • TMD Infrared Thermography Physical Therapy Modalities
04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age between 18 and 45 years;
  • presence of pain in the facial region in the last 6 months;
  • diagnosis of myofascial pain (I) and/or disc displacement (IIa and IIb) determined by the DRC/TMD; Moderate DTM Record carrier or determined by Fonseca Anamnesic Index.

Exclusion criteria

Exclusion Criteria:

  • A history of trauma/cervical surgery and/or craniofacial;
  • Neurological disorders;
  • cervical disc disease;
  • degenerative diseases of the spine;
  • systemic diseases;
  • diagnosis of fibromyalgia;
  • prior treatments for TMD for the last 3 months;
  • orthodontic treatment/orthopedic in progress;
  • continuous use of analgesics, anti-inflammatories, anxiolytics and/or antidepressants;
  • > 25 kg / m2;
  • pregnancy.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    Manual Therapy Treatment Group

    Severe and Moderate TMD patients who filled the inclusion criteria who will receive the Manual Therapy Treatment

    Other: Manual Therapy Treatment

  • Placebo comparator
    Placebo Ultrasound Treatment Group

    Severe and Moderate TMD patients who filled the inclusion criteria who will receive the Placebo Treatment.

    Device: Placebo Ultrasound

Interventions

  • OtherManual Therapy Treatment

    Treatment starts with 10 deep breathing movements for global relaxation. The anterior and posterior neck muscles, shoulder girdle and subdiaphragmatic will be addressed with myofascial techniques repeated 10 times in each stroke. The cervical spine will be pulled in the longitudinal direction. The draw will be held 1 time, lasting 1 minute. The thoracic region will receive mobilization technique in the anteroposterior direction,10 repeated movements involving all thoracic segment. The treatment will be applied previously trained therapists, 4 weeks, 2 times a week, totaling eight sessions. The treatment time per session is about 25 minutes.

  • DevicePlacebo Ultrasound

    A detuned pulsed ultrasound will be applied to regions of the muscles around the shoulder girdle and anterior posterior cervical, for 25 minutes (2.5 minutes in each zone ). The device will be used with the internal cables disconnected for the placebo effect . However, you can handle it and adjust the doses and alarms as it is connected in order to simulate clinical practice and increase the credibility of the use of this device in the voluntary . The placebo treatment will be applied by previously trained therapists. Treatment will have 4 weeks, 2 times a week, totaling eight sessions.

06

What researchers measure

Primary outcomes

  1. Changes in Skin Temperature

    Measured by the Infrared thermographic digital camera

    Time frame: Baseline and 4 weeks

Secondary outcomes

  1. Changes in TMD severity

    Measured by Fonseca´s Anamnesic Index

    Time frame: Baseline and 4 weeks

  2. Changes in Neck disability

    Measured by the Neck Disability Index

    Time frame: Baseline and 4 weeks

  3. Changes in Pain incapacity

    Measured by the IDD-CF

    Time frame: Baseline and 4 weeks

  4. Changes in Movement Range of Motion (Opening)

    Measured using a pachymeter (mean values of 3 opening measures)

    Time frame: Baseline and 4 weeks

  5. Changes in Referred Pain

    Measured by Visual Analogic Scale

    Time frame: Baseline and 4 weeks

07

Study locations

1 site
  • University of Nove de Julho
    Sao Paulo, São Paulo 01415000, Brazil
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jul 2016 to primary completion in Oct 2017, 15 months.

Of 244 non-industry interventional studies with no phase under Temporomandibular Joint Disorders, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 21. This study's 15 months is above that.

Counting every sponsor, half of 248 studies reached it within 11 months; a quarter within 5 and three quarters within 21.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 23, 2016
First posted
Jul 4, 2016
StartActual
Jul 2016
Primary completionActual
Oct 2017
CompletionActual
Dec 2017
Last update
Feb 21, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 21, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02822469
Lead sponsor
Daniela Ap. Biasotto-Gonzalez
Responsible party
Daniela Ap. Biasotto-Gonzalez (DR, University of Nove de Julho) — Sponsor-investigator
First posted
Jul 4, 2016
Start date
Jul 2016
Primary completion
Oct 2017
Completion
Dec 2017
Last update
Feb 21, 2022

Study contacts

Daniela Ap Biasotto-Gonzalez, PHD
study chair · Study Principal Investigator - Universidade Nove de Julho

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion